Coloplast A/S (CPH:COLO.B)
Denmark flag Denmark · Delayed Price · Currency is DKK
581.20
+14.00 (2.47%)
At close: Dec 5, 2025

Coloplast Revenue

In the fiscal year ending September 30, 2025, Coloplast had annual revenue of 27.87B DKK with 3.12% growth. Coloplast had revenue of 6.96B in the quarter ending September 30, 2025, with 0.10% growth.

Revenue
27.87B
Revenue Growth
+3.12%
P/S Ratio
4.70
Revenue / Employee
1.66M
Employees
16,744
Market Cap
130.98B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Sep 30, 202527.87B844.00M3.12%
Sep 30, 202427.03B2.53B10.33%
Sep 30, 202324.50B1.92B8.51%
Sep 30, 202222.58B3.15B16.23%
Sep 30, 202119.43B882.00M4.76%
Sep 30, 2020 Pro Pro Pro
Sep 30, 2019 Pro Pro Pro
Sep 30, 2018 Pro Pro Pro
Sep 30, 2017 Pro Pro Pro
Sep 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Novo Nordisk 315.60B
Genmab 24.48B
ALK-Abelló 6.08B
Demant 22.59B
H. Lundbeck 24.08B
Zealand Pharma 9.16B
Ambu A/S 6.04B
Embla Medical 5.71B
Revenue Rankings